Subscribe to RSS
Download PDF
DOI: 10.4103/ijmpo.ijmpo_227_18
Deluging Thrombosis: An Unusual Presentation of Acute Promyelocytic Leukemia
Financial support and sponsorship Nil.
Abstract
Acute promyelocytic leukemia (APML) patients are prone to thrombosis. However, thrombosis at presentation is rare in APML. Our patient presented with thrombosis and cytopenia, and the clinical diagnosis was of paroxysmal nocturnal hemoglobinuria. However, subsequent peripheral blood smear and bone marrow study confirmed the diagnosis of APML. The patient was successfully managed with anticoagulation, arsenic trioxide, and all-trans retinoic acid.
Publication History
Received: 17 October 2018
Accepted: 20 June 2019
Article published online:
23 May 2021
© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Falanga A, Barbui T. Coagulopathy of acute promyelocytic leukemia. Acta Haematol 2001; 106: 43-51
- 2 Choudhry A, DeLoughery TG. Bleeding and thrombosis in acute promyelocytic leukemia. Am J Hematol 2012; 87: 596-603
- 3 DiGiovanni Jr. RJ, Crilley P, Kerstein MD. Peripheral arterial occlusion in acute promyelocytic leukemia. Cardiovasc Surg 1999; 7: 258-60
- 4 Rashidi A, Silverberg ML, Conkling PR, Fisher SI. Thrombosis in acute promyelocytic leukemia. Thromb Res 2013; 131: 281-9
- 5 Tallman MS, Lefèbvre P, Baine RM, Shoji M, Cohen I, Green D. et al. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. J Thromb Haemost 2004; 2: 1341-50
- 6 Escudier SM, Kantarjian HM, Estey EH. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Leuk Lymphoma 1996; 20: 435-9
- 7 Dally N, Hoffman R, Haddad N, Sarig G, Rowe JM, Brenner B. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. Thromb Res 2005; 116: 109-14
- 8 Chotai PN, Kasangana K, Chandra AB, Rao AS. Recurrent arterial thrombosis as a presenting feature of a variant M3-acute promyelocytic leukemia. Vasc Specialist Int 2016; 32: 65-71
- 9 Jain A, Lad D, Malhotra P, Bommannan K. Acute promyelocytic leukaemia: Looking through ‘gums’. BMJ Case Rep 2016;2016. pii: bcr2016217457.
- 10 Malhotra P, Varma N, Arora N, Das R, Nath A, Patel FD. et al. Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: A series of three patients. Leuk Lymphoma 2010; 51: 933-6
- 11 Jandial A, Mishra K, Kumar S, Malhotra P. Pulmonary saddle thrombus. QJM 2018; 111: 907-8
- 12 Bhattacharyya D, Rajput AK, Mishra K. Medicine Update. 20. New Delhi: Jaypee Brothers Medical Publishers; 2010: 788-90